EANS-Adhoc: Intercell AG announces Q3 2012 financial results and provides operational update
9-month report 07.11.2012 » IXIARO®/JESPECT® - product sales growth trend continues despite lower than expected product sales of EUR 3.5m in Q3 2012 » U.S. military places largest IXIARO® order to date in Q4 2012 » Net loss for Q3 2012 slightly decreased by 2.8% to EUR 7.5m Q3 2012 Financial results » Total revenues decreased by 41.3% to EUR 4.4m in Q3 2012 ...